Document is current
Any future updates will be listed below
-
Authors
Johnson, Nick W. https://orcid.org/0000-0001-6389-2112
Valenzuela-Ortega, Marcos
Thorpe, Thomas W.
Era, Yuta https://orcid.org/0000-0002-1670-7110
Kjeldsen, Annemette
Mulholland, Keith
Wallace, Stephen https://orcid.org/0000-0003-1391-5800
-
Funding
Funding for this research was provided by:
RCUK | Engineering and Physical Sciences Research Council (EP/T517501/1, EP/W019000/1, EP/T517501/1)
Research Councils UK (MR/S033882/1, MR/S033882/1, MR/S033882/1, MR/S033882/1, MR/S033882/1)
- License Information
-
More Information
Article History
Received: 26 March 2024
Accepted: 2 May 2025
First Online: 23 June 2025
Competing interests
: N.W.J., M.V.-O., T.W.T., Y.E., A.K. and S.W. declare no competing interests. K.M. is an employee of AstraZeneca and may own stock options.
